Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Gdansk
Clinical trial register · Poland

Clinical Trials in Gdansk, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Poland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 2705 matching records held by the registry are in this view. Synced 28 Oct 2026, 03:18 UTC
2705
Studies in scope
all four open statuses
1389
Recruiting now
open to new participants
512
Lead sponsors
across recruiting studies
Top sites
Warsaw 44 Bydgoszcz 42 Lublin 36 Krakow 36 Gdansk 30
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
AstraZeneca59 Medical University of Gdansk32 Janssen Research & Development, LLC30 Merck Sharp & Dohme LLC27 Hoffmann-La Roche24 Clear sponsor filter
Site location
Warsaw44 Bydgoszcz42 Lublin36 Krakow36 Gdansk30
All 60 locations
Target enrolment
to

Trials with a site in Gdansk

30 of 2705 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Poland
Start
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bydgoszcz, Gdansk, Katowice, Lublin, Warsaw, Wałbrzych
2026-05-31
Recruiting
Janssen Research & Development, LLC
Phase 3
500
Gdansk, Gliwice, Lodz, Lublin, Poznan, Warsaw
2025-12-03
Recruiting
Janssen Research & Development, LLC
Phase 3
600
Bialystok, Bydgoszcz, Gdansk, Kielce, Lodz, Wroclaw
2025-06-04
By invitation
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
NCT06788509Leukemia, Myeloid, Acute, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes
DrugsJNJ-75348780·JNJ-87801493·JNJ-80948543·Ibrutinib
Janssen Research & Development, LLC
Phase 1
120
Gdansk, Krakow, Skorzewo
2024-12-30
Recruiting
Janssen Research & Development, LLC
Phase 2
480
Bydgoszcz, Bystra, Gdansk, Olsztyn, Warsaw
2024-12-16
Recruiting
Janssen Research & Development, LLC
Phase 3
700
Bialystok, Biała Podlaska, Brzozów, Gdansk, Gliwice, Lodz, Olsztyn, Opole
2024-12-12
Recruiting
Janssen Research & Development, LLC
Phase 3
1,000
Bialystok, Biała Podlaska, Brzozów, Gdansk, Gliwice, Lodz, Olsztyn, Opole
2024-10-18
Recruiting
Janssen Research & Development, LLC
Phase 3
752
Bydgoszcz, Gdansk, Gorlice, Grudziądz, Katowice, Leszno, Poznan, Warsaw
2024-07-25
Active, closed
Janssen Research & Development, LLC
Phase 1
108
Biała Podlaska, Gdansk, Katowice, Kielce, Lublin, Wroclaw
2024-06-07
Recruiting
Janssen Research & Development, LLC
Phase 1/2
287
Gdansk, Gliwice, Warsaw
2024-04-22
Active, closed
Janssen Research & Development, LLC
Phase 3
112
Gdansk, Rzeszów, Warsaw
2024-01-19
Active, closed
Janssen Research & Development, LLC
Phase 3
20,284
Biała Podlaska, Bydgoszcz, Chojnice, Chorzów, Chrzanów, Elblag, Gdansk, Gdynia
2023-04-11
Active, closed
Janssen Research & Development, LLC
Phase 3
614
Gdansk, Katowice, Kielce, Lublin
2023-03-29
Active, closed
Janssen Research & Development, LLC
Phase 1/2
57
Gdansk, Lublin, Warsaw
2022-12-13
Active, closed
Janssen Research & Development, LLC
Phase 3
864
Brzozów, Gdansk, Katowice, Kielce, Krakow, Lublin, Olsztyn, Szczecin
2022-10-13
Active, closed
Janssen Research & Development, LLC
Phase 1
167
Gdansk, Skorzewo
2022-08-18
Recruiting
Janssen Research & Development, LLC
Phase 2/3
12
Gdansk
2022-07-20
Active, closed
Janssen Research & Development, LLC
Phase 3
776
Bydgoszcz, Gdansk, Gdynia, Olsztyn, Poznan, Warsaw
2021-11-17
Active, closed
Janssen Research & Development, LLC
Phase 3
587
Gdansk, Katowice, Kielce, Lublin, Warsaw, Wałbrzych, Wroclaw
2021-10-14
Active, closed
Janssen Research & Development, LLC
Phase 3
743
Gdansk, Gliwice, Lublin, Poznan, Warsaw, Wroclaw
2021-08-19
Recruiting
Janssen Research & Development, LLC
Phase 2
510
Gdansk, Gliwice, Poznan, Warsaw, Wroclaw
2021-02-01
Active, closed
Janssen Research & Development, LLC
Phase 1
136
Gdansk, Warsaw
2020-11-13
Active, closed
Janssen Research & Development, LLC
Phase 3
308
Bydgoszcz, Gdansk, Gdynia, Olsztyn, Poznan, Warsaw
2020-10-13
Active, closed
Janssen Research & Development, LLC
Phase 3
1,074
Bydgoszcz, Gdansk, Gdynia, Olsztyn, Poznan, Warsaw
2020-09-30
Active, closed
Janssen Research & Development, LLC
Phase 3
419
Gdansk, Gliwice, Poznan, Warsaw
2020-06-12
Active, closed
Janssen Research & Development, LLC
Phase 2/3
118
Bialystok, Gdansk, Katowice, Lodz, Opole, Warsaw
2019-08-15
Active, closed
Janssen Research & Development, LLC
Phase 3
765
Bydgoszcz, Gdansk, Gdynia, Lodz, Siedlce, Szczecin, Warsaw, Wroclaw
2019-01-25
Active, closed
Janssen Research & Development, LLC
Phase 3
84
Bydgoszcz, Gdansk, Krakow, Olsztyn, Rzeszów, Warsaw
2018-10-29
Active, closed
Janssen Research & Development, LLC
Phase 2/3
1,409
Bydgoszcz, Chojnice, Częstochowa, Gdansk, Gdynia, Jelenia Góra, Katowice, Krakow
2018-04-13
Active, closed
A Long-term Extension Study of PCI-32765 (Ibrutinib)
NCT01804686Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Mantle Cell Lymphoma, Follicular Lymphoma
DrugIbrutinib
Janssen Research & Development, LLC
Phase 3
539
Brzozów, Chorzów, Gdansk, Klinika Nowotworow Ukladu Chlonnego, Krakow, Opole, Słupsk, Wroclaw
2013-09-09
Rows per page Showing 1–30 of 30
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Polish investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 29 October 2026. https://priyalifescience.com/clinical-trials-poland/city/gdansk

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Poland and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 2,705 studies in total at the last sync on 28 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 30 of those studies with a site in Gdansk that also match the filters currently applied.

How many clinical trials are recruiting in Gdansk?

10 of the 30 studies on this page are recruiting new participants as of the 28 Oct 2026, 03:18 UTC sync. A further 0 have not yet opened recruitment, 19 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Gdansk), 30 studies
PhaseStudiesRecruitingShare
Phase 319663.3%
Phase 14013.3%
Phase 2/33110%
Phase 1/2216.7%
Phase 2226.7%

Most active sponsors

Lead sponsors with the most studies (Gdansk)
Lead sponsorStudiesRecruiting
Janssen Research & Development, LLC3010
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.